AAAAAA

   
Results: 1-9 |
Results: 9
Tumor-induced immune dysfunctions caused by myeloid suppressor cells
Authors: Bronte, V Serafini, P Apolloni, E Zanovello, P
Citation: V. Bronte et al., Tumor-induced immune dysfunctions caused by myeloid suppressor cells, J IMMUNOTH, 24(6), 2001, pp. 431-446
Therapeutic tumor immunity induced by polyimmunization with melanoma antigens gp100 and TRP-2
Authors: Mendiratta, SK Thai, G Eslahi, NK Thull, NM Matar, M Bronte, V Pericle, F
Citation: Sk. Mendiratta et al., Therapeutic tumor immunity induced by polyimmunization with melanoma antigens gp100 and TRP-2, CANCER RES, 61(3), 2001, pp. 859-863
Interleukin-10 enhances the therapeutic effectiveness of a recombinant poxvirus-based vaccine in an experimental murine tumor model (vol 22, pg 489, 1999)
Authors: Kaufman, HL Rao, JB Irivine, KR Bronte, V Rosenberg, SA Restifo, NP
Citation: Hl. Kaufman et al., Interleukin-10 enhances the therapeutic effectiveness of a recombinant poxvirus-based vaccine in an experimental murine tumor model (vol 22, pg 489, 1999), J IMMUNOTH, 23(4), 2000, pp. 509-509
Antitumor vaccination: where we stand
Authors: Bocchia, M Bronte, V Colombo, MP De Vincentiis, A Di Nicola, M Forni, G Lanata, L Lemoli, RM Massaia, M Rondelli, D Zanon, P Tura, S
Citation: M. Bocchia et al., Antitumor vaccination: where we stand, HAEMATOLOG, 85(11), 2000, pp. 1172-1206
Immortalized myeloid suppressor cells trigger apoptosis in antigen-activated T lymphocytes
Authors: Apolloni, E Bronte, V Mazzoni, A Serafini, P Cabrelle, A Segal, DM Young, HA Zanovello, P
Citation: E. Apolloni et al., Immortalized myeloid suppressor cells trigger apoptosis in antigen-activated T lymphocytes, J IMMUNOL, 165(12), 2000, pp. 6723-6730
Genetic vaccination with "self" tyrosinase-related protein 2 causes melanoma eradication but not vitiligo
Authors: Bronte, V Apolloni, E Ronca, R Zamboni, P Overwijk, WW Surman, DR Restifo, NP Zanovello, P
Citation: V. Bronte et al., Genetic vaccination with "self" tyrosinase-related protein 2 causes melanoma eradication but not vitiligo, CANCER RES, 60(2), 2000, pp. 253-258
Identification of a CD11b(+)/Gr-1(+)/CD31(+) myeloid progenitor capable ofactivating or suppressing CD8(+) T cells
Authors: Bronte, V Apolloni, E Cabrelle, A Ronca, R Serafini, P Zamboni, P Restifo, NP Zanovello, P
Citation: V. Bronte et al., Identification of a CD11b(+)/Gr-1(+)/CD31(+) myeloid progenitor capable ofactivating or suppressing CD8(+) T cells, BLOOD, 96(12), 2000, pp. 3838-3846
Interleukin-10 enhances the therapeutic effectiveness of a recombinant poxvirus-based vaccine in an experimental murine tumor model
Authors: Kaufman, HL Rao, JB Irivine, KR Bronte, V Rosenberg, SA Restifo, NP
Citation: Hl. Kaufman et al., Interleukin-10 enhances the therapeutic effectiveness of a recombinant poxvirus-based vaccine in an experimental murine tumor model, J IMMUNOTH, 22(6), 1999, pp. 489-496
Unopposed production of granulocyte-macrophage colony-stimulating factor by tumors inhibits CD8(+) T cell responses by dysregulating antigen-presenting cell maturation
Authors: Bronte, V Chappell, DB Apolloni, E Cabrelle, K Wang, M Hwu, P Restifo, NP
Citation: V. Bronte et al., Unopposed production of granulocyte-macrophage colony-stimulating factor by tumors inhibits CD8(+) T cell responses by dysregulating antigen-presenting cell maturation, J IMMUNOL, 162(10), 1999, pp. 5728-5737
Risultati: 1-9 |